Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,815 across all filing types
Latest filing 2024-12-03 Director's Dealing
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document explicitly states it is a 'Company Announcement' disclosing transactions made by 'managerial employees and their closely associated persons' in accordance with 'Article 19 of Regulation No. 596/2014 on Market Abuse'. This regulation mandates the disclosure of insider trading or transactions by persons discharging managerial responsibilities (PDMRs). The content details the name, position, nature of the transaction (Acquisition due to vesting of restricted stock units), price, and volume for several individuals who are directors or board members. This perfectly matches the definition of Director's Dealing (insider trades by executives/directors). Classification Code: DIRS.
2024-12-03 English
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document is titled 'Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons' and explicitly states it discloses transactions made by managerial employees in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse. This regulation mandates the disclosure of insider transactions (trades by directors/managers). This directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions an attachment, the core content is the mandatory disclosure of insider transactions, not just an announcement of a report.
2024-12-03 English
6-K
Foreign Filer Report
2024-11-27 English
6-K
Foreign Filer Report
2024-11-21 English
6-K
Foreign Filer Report
2024-11-06 English
6-K
Foreign Filer Report
2024-10-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.